Healthcare Insights Weekly: MA Reinstated, Generic Dermatology Cream, Soaring IT Outsourcing, & AI Copilot for Epic
In this week’s edition, we explore key developments across Medicare Advantage, dermatology drug access, healthcare IT outsourcing growth, and innovative AI tools embedded in EHR systems.
CMS Lifts Medicare Advantage Enrollment Ban on Centene’s Missouri Plan
Regulators have lifted the enrollment suspension on Centene’s Wellcare of Missouri Medicare Advantage plan, allowing sign-ups again for the 2026 season. The prior suspension was imposed due to failure to meet the required 85% medical-loss ratio.
Extrovis & Dr. Reddy’s Launch Authorized Generic of CARAC Fluorouracil Cream
Extrovis AG and Dr. Reddy's introduced a USFDA-approved authorized generic 0.5% fluorouracil cream - therapeutically equivalent to Carac - for treating actinic keratoses. Manufactured in Texas, this alternative enhances patient access while promoting healthcare affordability.
Healthcare IT Outsourcing Market Projected to Skyrocket
The global healthcare IT outsourcing industry is expected to expand from $74.14 billion in 2024 to approximately $150.13 billion by 2034 - a CAGR of 7.31%. This growth reflects mounting demand for advanced digital, data, and EHR services across healthcare systems.
Ambience Healthcare Releases ‘Chart Chat’ - An AI Copilot for Epic EHRs
Ambience Healthcare has unveiled Chart Chat, the first AI copilot that seamlessly integrates with Epic EHR. It leverages patient records plus BMJ Best Practice clinical insights and OpenAI tech to deliver real-time, context-aware support within clinicians’ workflows.
Thank you for reading this week’s newsletter! Stay tuned for next week's edition, where we'll deliver more key stories shaping healthcare - policy changes, tech breakthroughs, and market trends. See you soon!